Surrozen Inc
XNAS:SRZN 4:00:00 PM EDT
| Market Cap (Intraday) | 217.12M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $25.80 |
| 50-Day MA | $24.10 |
| 200-Day MA | $15.85 |
Surrozen Inc Stock, XNAS:SRZN
171 Oyster Point Boulevard, Suite 400, South San Francisco, California 94080
United States of America
Phone: +1.650.489.9000
Number of Employees: 42
Description
Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.